OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Game changers: do new medications make lifestyle‐based treatment of obesity obsolete?
Kristina H. Lewis, Justin B. Moore, Jamy D. Ard
Obesity (2023) Vol. 32, Iss. 2, pp. 237-239
Open Access | Times Cited: 12
Kristina H. Lewis, Justin B. Moore, Jamy D. Ard
Obesity (2023) Vol. 32, Iss. 2, pp. 237-239
Open Access | Times Cited: 12
Showing 12 citing articles:
Opportunities and challenges following approval of resmetirom for MASH liver disease
Jeffrey V. Lazarus, Dana Ivancovsky‐Wajcman, Henry E. Mark, et al.
Nature Medicine (2024) Vol. 30, Iss. 12, pp. 3402-3405
Closed Access | Times Cited: 24
Jeffrey V. Lazarus, Dana Ivancovsky‐Wajcman, Henry E. Mark, et al.
Nature Medicine (2024) Vol. 30, Iss. 12, pp. 3402-3405
Closed Access | Times Cited: 24
Envisioning how to advance the MASH field
Alina M. Allen, Zobair M. Younossi, Anna Mae Diehl, et al.
Nature Reviews Gastroenterology & Hepatology (2024)
Closed Access | Times Cited: 13
Alina M. Allen, Zobair M. Younossi, Anna Mae Diehl, et al.
Nature Reviews Gastroenterology & Hepatology (2024)
Closed Access | Times Cited: 13
Race and Sex Disparities in Metabolic/Bariatric Surgery over 20 Years: A Cohort Study
Benjamin Grobman, Liyun He, Zhou Lan, et al.
Annals of Surgery Open (2025) Vol. 6, Iss. 1, pp. e540-e540
Open Access | Times Cited: 1
Benjamin Grobman, Liyun He, Zhou Lan, et al.
Annals of Surgery Open (2025) Vol. 6, Iss. 1, pp. e540-e540
Open Access | Times Cited: 1
A narrative review of lifestyle management guidelines for metabolic dysfunction-associated steatotic liver disease
Dana Ivancovsky‐Wajcman, Christopher J. Byrne, John Dillon, et al.
Hepatology (2024)
Open Access | Times Cited: 7
Dana Ivancovsky‐Wajcman, Christopher J. Byrne, John Dillon, et al.
Hepatology (2024)
Open Access | Times Cited: 7
Impact of Anti‐obesity Medication Initiation and Duration on Weight Loss
M. Rami Bailony, P Espinoza, Harun Yüksel, et al.
Obesity Science & Practice (2025) Vol. 11, Iss. 2
Open Access
M. Rami Bailony, P Espinoza, Harun Yüksel, et al.
Obesity Science & Practice (2025) Vol. 11, Iss. 2
Open Access
Contemporary Treatments for Obesity: Physical Activity in the Context of Antiobesity Medications
John M. Jakicic, Renee J. Rogers, Caroline M. Apovian
Translational Journal of the American College of Sports Medicine (2024) Vol. 9, Iss. 2
Open Access | Times Cited: 2
John M. Jakicic, Renee J. Rogers, Caroline M. Apovian
Translational Journal of the American College of Sports Medicine (2024) Vol. 9, Iss. 2
Open Access | Times Cited: 2
Lifestyle Intervention Requirements for Novel Antiobesity Medications—Necessary Adjunct or Harmful Gatekeeper?
Ilya Golovaty, Scott Hagan
JAMA Internal Medicine (2024)
Closed Access | Times Cited: 2
Ilya Golovaty, Scott Hagan
JAMA Internal Medicine (2024)
Closed Access | Times Cited: 2
Public Health Responsibilities in the Era of GLP-1 Receptor Agonists
Grace Wang, Eshaal Rahim, Soham Bari, et al.
Journal of Public Health Management and Practice (2024) Vol. 30, Iss. 6, pp. 777-779
Closed Access | Times Cited: 1
Grace Wang, Eshaal Rahim, Soham Bari, et al.
Journal of Public Health Management and Practice (2024) Vol. 30, Iss. 6, pp. 777-779
Closed Access | Times Cited: 1
What Is the Role of Public Health in the Era of GLP-1 Receptor Agonists
Justin B. Moore
Journal of Public Health Management and Practice (2024) Vol. 30, Iss. 6, pp. 775-776
Closed Access
Justin B. Moore
Journal of Public Health Management and Practice (2024) Vol. 30, Iss. 6, pp. 775-776
Closed Access
Novel Therapies for Nonalcoholic Steatohepatitis (NASH) and Cardiovascular Risk Reduction
Tarun Biswas, Angelica Lehker, Debabrata Mukherjee
Cardiovascular & Haematological Disorders - Drug Targets (2024) Vol. 24, Iss. 4, pp. 211-217
Closed Access
Tarun Biswas, Angelica Lehker, Debabrata Mukherjee
Cardiovascular & Haematological Disorders - Drug Targets (2024) Vol. 24, Iss. 4, pp. 211-217
Closed Access
Decoding Obesity Management Medications and the Journey to Informed Treatment Choices for Patients
Afton M. Koball, Gretchen E. Ames, Karen Grothe, et al.
Mayo Clinic Proceedings (2024)
Closed Access
Afton M. Koball, Gretchen E. Ames, Karen Grothe, et al.
Mayo Clinic Proceedings (2024)
Closed Access
A Scoping Review of Tailoring in Pediatric Obesity Interventions
Emily Fu, Cady Berkel, James L. Merle, et al.
Childhood Obesity (2024)
Closed Access
Emily Fu, Cady Berkel, James L. Merle, et al.
Childhood Obesity (2024)
Closed Access
